Back to results
US 2022/0089520 A1Published application
A process for the preparation of enantiomerically pure norepinephrine
AssigneeEdmond Pharma s.r.l.
InventorsMatteo Zacche', Pier Andrea Gatti, Fulvio Gerli, Davide Sbarbada, Fabio Rondina
Life of this patent
Estimating the term…
Abstract
The invention concerns a new, efficient process for the preparation of enantiomerically pure norepinephrine (also known as noradrenaline), or an addition salt thereof, using a catalytic hydrogenation system under hydrogen donor transfer. The invention also discloses a novel intermediate and the process for the preparation thereof.
Claims17
A process for the preparation of a single enantiomer of norepinephrine or of an addition salt thereof, the process comprising the following steps:
- a) reacting a compound of formula (IV)
- wherein X is halogen (F, Cl, Br, I), with benzylamine in a suitable solvent, using an auxiliary base, under the atmosphere of an inert gas, and isolating the resulting condensation product as an acid addition salt with a carboxylic acid, to give a compound of formula (III)
- wherein R is hydrogen, or the residue of an aliphatic, cycloaliphatic or aromatic monocarboxylic or dicarboxylic acid;
- b) enantioselective reduction of the benzylamino ketone acid addition salt of Formula III to give a single enantiomer of the benzylamino alcohol of Formula V
- wherein the carbon atom bearing the waxy bond can be in the (R) or (S) configuration;
- c) debenzylation of the single enantiomer of the compound of Formula V to give a single enantiomer of norepinephrine, and
- d) isolating the single enantiomer of norepinephrine as a free base or acid addition salt thereof.
4 more elements
A compound of Formula III
- wherein R is hydrogen, or the residue of an aliphatic, cycloaliphatic or aromatic monocarboxylic or dicarboxylic acid.
Dependencies are inferred from the claim text.